http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20050739-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D323-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D325-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C-
filingDate 2005-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_428512b9b8c26e9b5c3eb3a196d2c027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bd89739cdda496a23d16600f8f0974f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4afac31615ee56c98315a73e1117c9a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a861ef15b8014ccad2279a882a723f97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5f9df09fb54817515c059b05cc36d62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460d0e62ed0278ff3ab6d67962333c08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ed85fb1804bf847aa5dda70825d83fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2160dbc214211961948edc824420ed64
publicationDate 2006-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HR-P20050739-A2
titleOfInvention Cycloalkyl-substituted alkanoic acid derivatives, methods for the production thereof, and use thereof as a medicament
abstract The invention relates to arylcycloalkyl substituted alkanoic acid derivatives, as well as to their physiologically tolerable salts and physiologically functional derivatives. Described are compounds of formula (I), wherein the radicals have the meanings given, as well as their physiologically tolerable salts and processes for their production. These compounds are suitable for the treatment and / or prevention of disorders of fatty acid metabolism and glucose depletion disorders, as well as disorders in which insulin resistance plays a role.
priorityDate 2003-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793

Total number of triples: 67.